|View printer-friendly version|
|Array CEO Robert E. Conway to Speak at the Future Leaders in the Biotech Industry Conference|
BOULDER, Colo., Mar 16, 2004 /PRNewswire-FirstCall via COMTEX/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the Future Leaders in the Biotech Industry Conference on April 1 in New York City. The public is welcome to participate in the conference through an audio webcast on the Array BioPharma website.
Event: Future Leaders in the Biotech Industry Conference Presenter: Robert E. Conway, Chief Executive Officer, Array BioPharma Date: Thursday, April 1, 2004 Time: 10:40 a.m. Eastern Time Location: Millennium Broadway Hotel, New York City Audio Webcast: www.arraybiopharma.com
About Array BioPharma:
Array BioPharma is creating the next generation of orally active drugs by integrating the latest advances in chemistry, biology and informatics. Our drug development pipeline is focused primarily in cancer and inflammatory disease and includes several promising small molecule drugs that regulate well-validated targets in therapeutically valuable disease pathways. Array collaborates with leading pharmaceutical and biotechnology companies to design, create and optimize drug candidates across a broad range of therapeutic areas. For more information on Array, please go to www.arraybiopharma.com.
SOURCE Array BioPharma Inc.
Tricia Haugeto of Array BioPharma Inc., +1-303-386-1193, email@example.com